263 related articles for article (PubMed ID: 34495156)
21. Natural Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Molecular Docking and Simulation Approach to Combat COVID-19.
Rehman MT; AlAjmi MF; Hussain A
Curr Pharm Des; 2021; 27(33):3577-3589. PubMed ID: 33200697
[TBL] [Abstract][Full Text] [Related]
22. In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors.
Ibrahim MAA; Abdelrahman AHM; Hussien TA; Badr EAA; Mohamed TA; El-Seedi HR; Pare PW; Efferth T; Hegazy MF
Comput Biol Med; 2020 Nov; 126():104046. PubMed ID: 33065388
[TBL] [Abstract][Full Text] [Related]
23. Computational Evidences of Phytochemical Mediated Disruption of PLpro Driven Replication of SARS-CoV-2: A Therapeutic Approach against COVID-19.
Balkrishna A; Mittal R; Arya V
Curr Pharm Biotechnol; 2021; 22(10):1350-1359. PubMed ID: 33176643
[TBL] [Abstract][Full Text] [Related]
24. De novo design of novel protease inhibitor candidates in the treatment of SARS-CoV-2 using deep learning, docking, and molecular dynamic simulations.
Arshia AH; Shadravan S; Solhjoo A; Sakhteman A; Sami A
Comput Biol Med; 2021 Dec; 139():104967. PubMed ID: 34739968
[TBL] [Abstract][Full Text] [Related]
25. Exploration of natural compounds with anti-SARS-CoV-2 activity via inhibition of SARS-CoV-2 Mpro.
Bharadwaj S; Dubey A; Yadava U; Mishra SK; Kang SG; Dwivedi VD
Brief Bioinform; 2021 Mar; 22(2):1361-1377. PubMed ID: 33406222
[TBL] [Abstract][Full Text] [Related]
26. Optimization Rules for SARS-CoV-2 M
Stoddard SV; Stoddard SD; Oelkers BK; Fitts K; Whalum K; Whalum K; Hemphill AD; Manikonda J; Martinez LM; Riley EG; Roof CM; Sarwar N; Thomas DM; Ulmer E; Wallace FE; Pandey P; Roy S
Viruses; 2020 Aug; 12(9):. PubMed ID: 32859008
[TBL] [Abstract][Full Text] [Related]
27. An investigation for the interaction of gamma oryzanol with the Mpro of SARS-CoV-2 to combat COVID-19: DFT, molecular docking, ADME and molecular dynamics simulations.
Raman APS; Singh MB; Vishvakarma VK; Jain P; Kumar A; Sachdeva S; Kumari K; Singh P
J Biomol Struct Dyn; 2023 Mar; 41(5):1919-1929. PubMed ID: 35067190
[TBL] [Abstract][Full Text] [Related]
28. Combined molecular docking and dynamics simulations studies of natural compounds as potent inhibitors against SARS-CoV-2 main protease.
Ouassaf M; Belaidi S; Chtita S; Lanez T; Abul Qais F; Md Amiruddin H
J Biomol Struct Dyn; 2022; 40(21):11264-11273. PubMed ID: 34315340
[TBL] [Abstract][Full Text] [Related]
29. Discovery of potent inhibitors for SARS-CoV-2's main protease by ligand-based/structure-based virtual screening, MD simulations, and binding energy calculations.
Abu-Saleh AAA; Awad IE; Yadav A; Poirier RA
Phys Chem Chem Phys; 2020 Oct; 22(40):23099-23106. PubMed ID: 33025993
[TBL] [Abstract][Full Text] [Related]
30. Dietary polyphenols mitigate SARS-CoV-2 main protease (Mpro)-Molecular dynamics, molecular mechanics, and density functional theory investigations.
Adelusi TI; Oyedele AK; Monday OE; Boyenle ID; Idris MO; Ogunlana AT; Ayoola AM; Fatoki JO; Kolawole OE; David KB; Olayemi AA
J Mol Struct; 2022 Feb; 1250():131879. PubMed ID: 34785822
[TBL] [Abstract][Full Text] [Related]
31. SAR, Molecular Docking and Molecular Dynamic Simulation of Natural Inhibitors against SARS-CoV-2 Mpro Spike Protein.
Salamat A; Kosar N; Mohyuddin A; Imran M; Zahid MN; Mahmood T
Molecules; 2024 Mar; 29(5):. PubMed ID: 38474656
[TBL] [Abstract][Full Text] [Related]
32. Leucoefdin a potential inhibitor against SARS CoV-2 M
Singh A; Mishra A
J Biomol Struct Dyn; 2021 Aug; 39(12):4427-4432. PubMed ID: 34281489
[TBL] [Abstract][Full Text] [Related]
33. Exploring the inhibitory potential of novel piperidine-derivatives against main protease (M
Rafique A; Muhammad S; Iqbal J; Al-Sehemi AG; Alshahrani MY; Ayub K; Gilani MA
J Mol Liq; 2023 Jul; 382():121904. PubMed ID: 37151376
[TBL] [Abstract][Full Text] [Related]
34. In silico and in vitro prediction of new synthesized N-heterocyclic compounds as anti-SARS-CoV-2.
Hashem HE; Ahmad S; Kumer A; Bakri YE
Sci Rep; 2024 Jan; 14(1):1152. PubMed ID: 38212472
[TBL] [Abstract][Full Text] [Related]
35. Analysis of bioactive compounds of
Almatroudi A
J Biomol Struct Dyn; 2023 Dec; ():1-12. PubMed ID: 38063160
[TBL] [Abstract][Full Text] [Related]
36. Identification of potential natural inhibitors of SARS-CoV2 main protease by molecular docking and simulation studies.
Gupta S; Singh AK; Kushwaha PP; Prajapati KS; Shuaib M; Senapati S; Kumar S
J Biomol Struct Dyn; 2021 Aug; 39(12):4334-4345. PubMed ID: 32476576
[TBL] [Abstract][Full Text] [Related]
37. Molecular dynamics and absolute binding free energy studies of piperine derivatives as potential inhibitors of SARS-CoV-2 main protease.
Amperayani KR; Varadhi G; Oruganti B; Parimi UD
J Biomol Struct Dyn; 2023; 41(23):13696-13706. PubMed ID: 36995111
[TBL] [Abstract][Full Text] [Related]
38. Identification of natural compounds (proanthocyanidin and rhapontin) as high-affinity inhibitors of SARS-CoV-2 Mpro and PLpro using computational strategies.
AlAjmi MF; Azhar A; Hasan S; Alshabr AZ; Hussain A; Rehman MT
Arch Med Sci; 2024; 20(2):567-581. PubMed ID: 38757037
[TBL] [Abstract][Full Text] [Related]
39. Structure-based screening of novel lichen compounds against SARS Coronavirus main protease (Mpro) as potentials inhibitors of COVID-19.
Joshi T; Sharma P; Joshi T; Pundir H; Mathpal S; Chandra S
Mol Divers; 2021 Aug; 25(3):1665-1677. PubMed ID: 32602074
[TBL] [Abstract][Full Text] [Related]
40. Exploring the potential of novel phenolic compounds as potential therapeutic candidates against SARS-CoV-2, using quantum chemistry, molecular docking and dynamic studies.
Zia M; Muhammad S; Shafiq-urRehman ; Bibi S; Abbasi SW; Al-Sehemi AG; Chaudhary AR; Bai FQ
Bioorg Med Chem Lett; 2021 Jul; 43():128079. PubMed ID: 33940136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]